1 The PRIME trial: Improving health centres to reduce childhood malaria in Uganda
- 1.1 PROCESS: Evaluating how the PRIME intervention worked in practice
2 Use of rapid diagnostic tests to improve malaria treatment in the community in Uganda
3 Introducing rapid diagnostic tests in drug shops to improve the targeting of malaria treatment
- 3.1 Perceptions and impact of introducing rapid diagnostic tests in drug shops
4 IMPACT 2: Evaluating policies in Tanzania to improve malaria diagnosis and treatment
5.1 Cost-effectiveness of interventions to support the introduction of malaria rapid diagnostic tests in Cameroon
5.2 Costs and effects of strategies to improve malaria diagnosis and treatment in Nigeria
6 Strategies for expanding access to quality malaria diagnosis in south-central Asia where malaria incidence is low
7 Trusting rapid diagnostic tests in Zanzibar
- 7.1 Identifying causes of fever in children under five in Zanzibar
8 Restricting ACT drugs to patients with positive rapid diagnostic test results
9 Targeting ACT drugs: the TACT trial
10 InterACT: Interactions between malaria and HIV drugs in a malaria endemic area
- 10.1 Understanding perceptions of HIV-positive people taking malaria treatment
11 The ACTia trial: Safety of repeated drug use in children
- 11.1 How perceptions of malaria medication affect adherence
- 11.2 Malaria indicator survey to support national control programmes
12 Collating drug safety data from ACT Consortium studies
13 Interactions between malaria and HIV drugs in people living with HIV
- 13.1 Collecting safety data in antimalarial drug trials
14 Analysing the quality and authenticity of ACT drugs
15 How the use of rapid diagnostic tests influences clinicians decision to prescribe ACTs
16 Identifying non-malaria illnesses that cause fever
17 Access and quality of malaria diagnosis and treatment in South-East Asia

Projects

Restricting ACT drugs to patients with positive rapid diagnostic test results

Start date: 1 Jan 2009 | Ghana

[Project summary in Français / Português]

Scientific title: Effects of Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial (RDT-ACT)
Analysing the quality and authenticity of ACT drugs

Start date: 1 Sep 2008 | Cambodia, Equatorial Guinea, Ghana, Nigeria, Tanzania

[Project summary in Français / Português]

Scientific title: Development of standardized methods for efficient representative sampling of drugs for laboratory analysis to obtain robust estimates of the frequency of counterfeit, substandard and degraded artemisinin containing drugs in countries.
How the use of rapid diagnostic tests influences clinicians decision to prescribe ACTs

| Ghana

[Project summary in Français / Português]

Scientific title: Social and economic evaluations of the introduction of rapid diagnostic tests for Malaria alongside a randomised controlled trial in rural health facilities in Ghana

ACT

Projects

Restricting ACT drugs to patients with positive rapid diagnostic test results

Analysing the quality and authenticity of ACT drugs

How the use of rapid diagnostic tests influences clinicians decision to prescribe ACTs